Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Reports First Quarter 2023 Financial Results
May 08, 2023 16:01 ET | FibroGen, Inc.
• Topline Data From Four Phase 3 Trials Expected Through 3Q 2023 • Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value • Entered Into...